Pulmonary vasculature in COPD: The silent component-Reference-Cited by-同舟云学术

Pulmonary vasculature in COPD: The silent component

Published:2016-03-30 Issue:6 Volume:21 Page:984-994
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Blanco Isabel¹,Piccari Lucilla¹,Barberà Joan Albert¹

Affiliation:

1. Department of Pulmonary Medicine; Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); University of Barcelona and Biomedical Research Networking Center in Respiratory Diseases (CIBERES); Madrid Spain

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12772/fullpdf

Reference90 articles.

1. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review;Kovacs;Eur. Respir. J.,2009

2. Dana Point: what is new in the diagnosis of pulmonary hypertension?;Olschewski;Dtsch. Med. Wochenschr.,2008

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie;Eur. Respir. J.,2015

4. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease;Andersen;J. Heart Lung Transplant.,2012

5. Categorization and impact of pulmonary hypertension in patients with advanced COPD;Cuttica;Respir. Med.,2010

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets;Non-coding RNA Research;2024-12

2. TGFβ1, SMAD and β-catenin in pulmonary arteries of smokers, patients with small airway disease and COPD: potential drivers of EndMT;Clinical Science;2024-08-28

3. Differences in Exercise Capacity, Ventilatory Efficiency, and Gas Exchange between Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Residing at High Altitude;Reviews in Cardiovascular Medicine;2024-07-04

4. Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2024-05

5. Determination of pulmonary vessel alteration in Chinese male smokers by quantitative computed tomography measurements: a retrospective study;Quantitative Imaging in Medicine and Surgery;2024-05